@article{royston,
  title={Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling},
  author={Royston, Patrick and Altman, Douglas G},
  journal={Journal of the Royal Statistical Society: Series C (Applied Statistics)},
  volume={43},
  number={3},
  pages={429--453},
  year={1994},
  publisher={Wiley Online Library}
}

@book{dias,
  title={Network meta-analysis for decision-making},
  author={Dias, Sofia and Ades, Anthony E and Welton, Nicky J and Jansen, Jeroen P and Sutton, Alexander J},
  year={2018},
  publisher={John Wiley \& Sons}
}

@article{guyotipd,
  title={Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves},
  author={Guyot, Patricia and Ades, AE and Ouwens, Mario JNM and Welton, Nicky J},
  journal={BMC medical research methodology},
  volume={12},
  pages={1--13},
  year={2012},
  publisher={Springer}
}

@misc{wpd,
  url = {https://automeris.io/WebPlotDigitizer},
  author = {Rohatgi,  Ankit},
  title = {Webplotdigitizer: Version 4.6},
  year = {2022}
}

@article{long2010,
  title={Using fractional polynomials to model non-linear trends in longitudinal data},
  author={Long, Jeffrey and Ryoo, Jihoon},
  journal={British Journal of Mathematical and Statistical Psychology},
  volume={63},
  number={1},
  pages={177--203},
  year={2010},
  publisher={Wiley Online Library}
}

@article{cox1972,
  title={Regression models and life-tables},
  author={Cox, David R},
  journal={Journal of the Royal Statistical Society: Series B (Methodological)},
  volume={34},
  number={2},
  pages={187--202},
  year={1972},
  publisher={Wiley Online Library}
}

@article{tsd2,
  title={NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials},
  author={Dias, Sofia and Welton, Nicky J and Sutton, Alex J and Ades, AE},
  year={2011},
  publisher={National Institute for Health and Clinical Excellence}
}

@article{NG85,
  author       = {{National Institute for Health and Care Excellence}},
  howpublished = {online},
  title        = {Pancreatic cancer in adults: diagnosis and management},
  year         = {2018},
  url          = {https://www.nice.org.uk/guidance/ng85}
}

@article{TA476,
  author       = {{National Institute for Health and Care Excellence}},
  howpublished = {online},
  title        = {Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer},
  year         = {2017},
  url          = {https://www.nice.org.uk/guidance/ta476/}
}

@article{flexsurv,
  title={flexsurv: a platform for parametric survival modeling in R},
  author={Jackson, Christopher H},
  journal={Journal of statistical software},
  volume={70},
  year={2016},
  publisher={Europe PMC Funders}
}

@article{colucci2010,
  title={Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.},
  author={Colucci, Giuseppe and Labianca, Roberto and Di Costanzo, Francesco and Gebbia, Vittorio and Carten{\`\i}, Giacomo and Massidda, Bruno and Dapretto, Elisa and Manzione, Luigi and Piazza, Elena and Sannicolo, Mirella and others},
  year={2010}
}

@article{reni2005,
  title={Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial},
  author={Reni, Michele and Cordio, Stefano and Milandri, Carlo and Passoni, Paolo and Bonetto, Elisa and Oliani, Cristina and Luppi, Gabriele and Nicoletti, Roberto and Galli, Laura and Bordonaro, Roberto and others},
  journal={The lancet oncology},
  volume={6},
  number={6},
  pages={369--376},
  year={2005},
  publisher={Elsevier}
}

@article{alv2014,
  title={PharmGKB summary: gemcitabine pathway},
  author={Alvarellos, Maria L and Lamba, Jatinder and Sangkuhl, Katrin and Thorn, Caroline F and Wang, Liewei and Klein, Daniel J and Altman, Russ B and Klein, Teri E},
  journal={Pharmacogenetics and genomics},
  volume={24},
  number={11},
  pages={564},
  year={2014},
  publisher={NIH Public Access}
}

@article{wong2009,
  title={Clinical pharmacology and pharmacogenetics of gemcitabine},
  author={Wong, Andrea and Soo, Ross A and Yong, Wei-Peng and Innocenti, Federico},
  journal={Drug metabolism reviews},
  volume={41},
  number={2},
  pages={77--88},
  year={2009},
  publisher={Taylor \& Francis}
}

@article{lu2009,
  title={Modeling between-trial variance structure in mixed treatment comparisons},
  author={Lu, Guobing and Ades, AE},
  journal={Biostatistics},
  volume={10},
  number={4},
  pages={792--805},
  year={2009},
  publisher={Oxford University Press}
}

@online{pancStat,
  author = {{Cancer Research UK}},
  title = {Pancreatic Cancer Statistics},
  url = {https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer#heading-Zero},
  organization = {Cancer Research UK},
  year = {2024}
}

@article{blackford,
  title={Genetic mutations associated with cigarette smoking in pancreatic cancer},
  author={Blackford, Amanda and Parmigiani, Giovanni and Kensler, Thomas W and Wolfgang, Christopher and Jones, Si{\^a}n and Zhang, Xiaosong and Parsons, D Willams and Lin, Jimmy Cheng-Ho and Leary, Rebecca J and Eshleman, James R and others},
  journal={Cancer research},
  volume={69},
  number={8},
  pages={3681--3688},
  year={2009},
  publisher={AACR}
}

@article{deeb,
  title={Pulmonary metastases in pancreatic cancer, is there a survival influence?},
  author={Deeb, Ayham and Haque, Sulsal-Ul and Olowokure, Olugbenga},
  journal={Journal of gastrointestinal oncology},
  volume={6},
  number={3},
  pages={E48},
  year={2015},
  publisher={AME Publications}
}

@article{kelsen,
  title={Pain as a predictor of outcome in patients with operable pancreatic carcinoma},
  author={Kelsen, David P and Portenoy, Russell and Thaler, Howard and Tao, Yue and Brennan, Murray},
  journal={Surgery},
  volume={122},
  number={1},
  pages={53--59},
  year={1997},
  publisher={Elsevier}
}

@online{pancSymp,
  author = {{Pancreatic Cancer UK}},
  title = {Signs and Symptoms of Pancreatic Cancer},
  url = {https://www.pancreaticcancer.org.uk/information/signs-and-symptoms-of-pancreatic-cancer/?gad_source=1},
  organization = {Pancreatic Cancer UK},
  year = {2022}
}

@article{tsd14,
  title={NICE DSU technical support document 14: survival analysis for economic evaluations alongside clinical trials-extrapolation with patient-level data},
  author={Latimer, Nicholas},
  journal={Report by the Decision Support Unit},
  year={2011}
}

@Manual{purrr,
  title = {purrr: Functional Programming Tools},
  author = {Hadley Wickham and Lionel Henry},
  year = {2023},
  note = {R package version 1.0.2, https://github.com/tidyverse/purrr},
  url = {https://purrr.tidyverse.org/},
}

@article{cunningham2009,
  title={Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer},
  author={Cunningham, David and Chau, Ian and Stocken, Deborah D and Valle, Juan W and Smith, David and Steward, William and Harper, Peter G and Dunn, Janet and Tudur-Smith, Catrin and West, Julia and others},
  journal={Journal of Clinical Oncology},
  volume={27},
  number={33},
  pages={5513--5518},
  year={2009},
  publisher={American Society of Clinical Oncology}
}

@article{kindler2011,
  title={Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study},
  author={Kindler, Hedy L and Ioka, Tatsuya and Richel, Dirk J and Bennouna, Jaafar and L{\'e}tourneau, Richard and Okusaka, Takuji and Funakoshi, Akihiro and Furuse, Junji and Park, Young Suk and Ohkawa, Shinichi and others},
  journal={The lancet oncology},
  volume={12},
  number={3},
  pages={256--262},
  year={2011},
  publisher={Elsevier}
}

@article{oettle2005,
  title={A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer},
  author={Oettle, Helmut and Richards, D and Ramanathan, RK and Van Laethem, Jean-Luc and Peeters, Marc and Fuchs, M and Zimmermann, A and John, W and Von Hoff, D and Arning, M and others},
  journal={Annals of Oncology},
  volume={16},
  number={10},
  pages={1639--1645},
  year={2005},
  publisher={Elsevier}
}

@article{rocha2004,
  title={Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate},
  author={Rocha Lima, Caio M and Green, Mark R and Rotche, Robert and Miller Jr, Wilson H and Jeffrey, G Mark and Cisar, Laura A and Morganti, Adele and Orlando, Nicoletta and Gruia, Gabriela and Miller, Langdon L},
  journal={Journal of Clinical Oncology},
  volume={22},
  number={18},
  pages={3776--3783},
  year={2004},
  publisher={American Society of Clinical Oncology}
}

@article{phillippo2024,
  title={Multilevel network meta-regression for general likelihoods: synthesis of individual and aggregate data with applications to survival analysis},
  author={Phillippo, David M and Dias, Sofia and Welton, Nicky J and Ades, AE},
  journal={arXiv preprint arXiv:2401.12640},
  year={2024}
}

@article{gresham2014,
  title={Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis},
  author={Gresham, Gillian K and Wells, George A and Gill, Sharlene and Cameron, Christopher and Jonker, Derek J},
  journal={BMC cancer},
  volume={14},
  pages={1--13},
  year={2014},
  publisher={Springer}
}

@article{goldstein2015,
  title={nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial},
  author={Goldstein, David and El-Maraghi, Robert Hassan and Hammel, Pascal and Heinemann, Volker and Kunzmann, Volker and Sastre, Javier and Scheithauer, Werner and Siena, Salvatore and Tabernero, Josep and Teixeira, Luis and others},
  journal={Journal of the National Cancer Institute},
  volume={107},
  number={2},
  pages={dju413},
  year={2015},
  publisher={Oxford University Press US}
}

@article{gonccalves2012,
  title={BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer},
  author={Gon{\c{c}}alves, A and Gilabert, M and Fran{\c{c}}ois, E and Dahan, L and Perrier, H and Lamy, R and Re, D and Largillier, R and Gasmi, M and Tchiknavorian, X and others},
  journal={Annals of oncology},
  volume={23},
  number={11},
  pages={2799--2805},
  year={2012},
  publisher={Elsevier}
}

@article{spano2008,
  title={Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study},
  author={Spano, Jean-Philippe and Chodkiewicz, Catherine and Maurel, Joan and Wong, Ralph and Wasan, Harpreet and Barone, Carlo and L{\'e}tourneau, Richard and Bajetta, Emilio and Pithavala, Yazdi and Bycott, Paul and others},
  journal={The Lancet},
  volume={371},
  number={9630},
  pages={2101--2108},
  year={2008},
  publisher={Elsevier}
}

@Manual{multinma,
  title = {multinma: Bayesian Network Meta-Analysis of Individual and Aggregate Data},
  author = {David M. Phillippo},
  year = {2023},
  note = {R package version 0.7.1},
  url = {https://dmphillippo.github.io/multinma/},
  doi = {10.5281/zenodo.3904454},
}

@Article{simsurv,
  title = {Simulating Survival Data Using the {simsurv} {R} Package},
  author = {Samuel L. Brilleman and Rory Wolfe and Margarita
    Moreno-Betancur and Michael J. Crowther},
  journal = {Journal of Statistical Software},
  year = {2020},
  volume = {97},
  number = {3},
  pages = {1--27},
  doi = {10.18637/jss.v097.i03},
}

@Misc{loo,
  title = {loo: Efficient leave-one-out cross-validation and WAIC for
    Bayesian models},
  author = {Aki Vehtari and Jonah Gabry and Mans Magnusson and Yuling
    Yao and Paul-Christian BÃ¼rkner and Topi Paananen and Andrew
    Gelman},
  year = {2024},
  note = {R package version 2.7.0},
  url = {https://mc-stan.org/loo/},
}

@article{sobol,
  title={On the distribution of points in a cube and the approximate evaluation of integrals},
  author={Sobol', Il'ya Meerovich},
  journal={Zhurnal Vychislitel'noi Matematiki i Matematicheskoi Fiziki},
  volume={7},
  number={4},
  pages={784--802},
  year={1967},
  publisher={Russian Academy of Sciences, Branch of Mathematical Sciences}
}

@article{phillippo2020,
  title={Multilevel network meta-regression for population-adjusted treatment comparisons},
  author={Phillippo, David M and Dias, Sofia and Ades, AE and Belger, Mark and Brnabic, Alan and Schacht, Alexander and Saure, Daniel and Kadziola, Zbigniew and Welton, Nicky J},
  journal={Journal of the Royal Statistical Society Series A: Statistics in Society},
  volume={183},
  number={3},
  pages={1189--1210},
  year={2020},
  publisher={Oxford University Press}
}

@article{conroy,
  title={FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer},
  author={Conroy, Thierry and Desseigne, Fran{\c{c}}oise and Ychou, Marc and Bouch{\'e}, Olivier and Guimbaud, Rosine and B{\'e}couarn, Yves and Adenis, Antoine and Raoul, Jean-Luc and Gourgou-Bourgade, Sophie and De La Fouchardi{\`e}re, Christelle and others},
  journal={New England journal of medicine},
  volume={364},
  number={19},
  pages={1817--1825},
  year={2011},
  publisher={Mass Medical Soc}
}

@article{jansengp,
  title={Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report},
  author={Jansen, Jeroen P and Trikalinos, Thomas and Cappelleri, Joseph C and Daw, Jessica and Andes, Sherry and Eldessouki, Randa and Salanti, Georgia},
  journal={Value in Health},
  volume={17},
  number={2},
  pages={157--173},
  year={2014},
  publisher={Elsevier}
}

@article{vehtari,
  title={Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC},
  author={Vehtari, Aki and Gelman, Andrew and Gabry, Jonah},
  journal={Statistics and computing},
  volume={27},
  pages={1413--1432},
  year={2017},
  publisher={Springer}
}

@article{takumoto,
  title={Comparative outcomes of first-line chemotherapy for metastatic pancreatic cancer among the regimens used in Japan: a systematic review and network meta-analysis},
  author={Takumoto, Yuki and Sasahara, Yuriko and Narimatsu, Hiroto and Akazawa, Manabu},
  journal={JAMA Network Open},
  volume={5},
  number={1},
  pages={e2145515--e2145515},
  year={2022},
  publisher={American Medical Association}
}

@article{zhang,
  title={Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: a network meta-analysis},
  author={Zhang, Shu-Hua and Liu, Gui-Feng and Li, Xue-Feng and Liu, Lin and Yu, Shao-Nan},
  journal={Journal of Cellular Physiology},
  volume={233},
  number={4},
  pages={3352--3374},
  year={2018},
  publisher={Wiley Online Library}
}

@article{nichetti,
  title={NALIRIFOX, FOLFIRINOX, and gemcitabine with nab-paclitaxel as first-line chemotherapy for metastatic pancreatic cancer: a systematic review and meta-analysis},
  author={Nichetti, Federico and Rota, Simone and Ambrosini, Paolo and Pircher, Chiara and Gusmaroli, Eleonora and Busset, Michele Droz Dit and Pusceddu, Sara and Sposito, Carlo and Coppa, Jorgelina and Morano, Federica and others},
  journal={JAMA Network Open},
  volume={7},
  number={1},
  pages={e2350756--e2350756},
  year={2024},
  publisher={American Medical Association}
}

@article{lin,
  title={Network meta-analysis of efficacy and safety of chemotherapy and target therapy in the first-line setting of advanced pancreatic cancer},
  author={Lin, Kun-I and Yang, Jia-Lian and Lin, Yu-Chao and Chou, Che-Yi and Chen, Jin-Hua and Hung, Chin-Chuan},
  journal={Cancers},
  volume={11},
  number={11},
  pages={1746},
  year={2019},
  publisher={MDPI}
}

@article{chen,
  title={Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer},
  author={Chen, Jiayuan and Hua, Qingling and Wang, Haihong and Zhang, Dejun and Zhao, Lei and Yu, Dandan and Pi, Guoliang and Zhang, Tao and Lin, Zhenyu},
  journal={BMC cancer},
  volume={21},
  pages={1--9},
  year={2021},
  publisher={Springer}
}

@article{matsumoto,
  title={FOLFIRINOX for advanced pancreatic cancer patients after nab-paclitaxel plus gemcitabine failure},
  author={Matsumoto, Toshihiko and Kurioka, Yusuke and Okazaki, Ukyo and Matsuo, Yu and Kimura, Shogo and Miura, Kou and Tsuduki, Takao and Takagi, Shinjiro and Takatani, Masahiro and Morishita, Hirofumi},
  journal={Pancreas},
  volume={49},
  number={4},
  pages={574--578},
  year={2020},
  publisher={LWW}
}

@article{chung,
  title={Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer},
  author={Chung, Moon Jae and Kang, Huapyong and Kim, Ho Gak and Hyun, Jong Jin and Lee, Jun Kyu and Lee, Kwang Hyuck and Noh, Myung Hwan and Kang, Dae Hwan and Lee, Sang Hyub and Bang, Seungmin and others},
  journal={World journal of gastrointestinal oncology},
  volume={10},
  number={12},
  pages={505},
  year={2018},
  publisher={Baishideng Publishing Group Inc}
}

@article{dimagno,
  title={Pancreatic cancer: clinical presentation, pitfalls and early clues},
  author={Dimagno, Eugene P},
  journal={Annals of oncology},
  volume={10},
  pages={S140--S142},
  year={1999},
  publisher={Elsevier}
}

@article{ingram,
  title={Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients},
  author={Ingram, Myles A and Lauren, Brianna N and Pumpalova, Yoanna and Park, Jiheum and Lim, Francesca and Bates, Susan E and Kastrinos, Fay and Manji, Gulam A and Kong, Chung Yin and Hur, Chin},
  journal={Cancer Reports},
  volume={5},
  number={9},
  pages={e1565},
  year={2022},
  publisher={Wiley Online Library}
}

@article{kharat,
  title={Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trials},
  author={Kharat, Aditi A and Nelson, Richard and Au, Trang and Biskupiak, Joseph},
  journal={Journal of Managed Care \& Specialty Pharmacy},
  volume={27},
  number={10},
  pages={1367--1375},
  year={2021},
  publisher={Academy of Managed Care Pharmacy}
}

@article{TA25,
  author       = {{National Institute for Health and Care Excellence}},
  howpublished = {online},
  title        = {Guidance on the use of gemcitabine for the treatment of pancreatic cancer},
  year         = {2017},
  url          = {https://www.nice.org.uk/guidance/ta25/}
}

@article{pishvaian,
  title={Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.},
  author={Pishvaian, Michael J and Brody, Jonathan R},
  journal={Oncology (Williston Park, NY)},
  volume={31},
  number={3},
  pages={159--66},
  year={2017}
}

@book{neoptolemos,
  title={Pancreatic Cancer},
  author={Neoptolemos, J.P. and Urrutia, R.A. and Abbruzzese, J. and B{\"u}chler, M.W.},
  isbn={9780387774978},
  lccn={2009937021},
  series={2010 Springer E-Books},
  url={https://books.google.co.uk/books?id=NmBB5ZoKkk4C},
  year={2010},
  publisher={Springer}
}